⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TENX News
Tenax Therapeutics, Inc.
Tenax Therapeutics Announces Result of Prespecifed Blinded Sample Size Assessment
globenewswire.com
TENX
Tenax Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
TENX
Tenax Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
globenewswire.com
TENX
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 (Oral Levosimendan) for the Treatment of PH-HFpEF
globenewswire.com
TENX
Tenax Therapeutics to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
globenewswire.com
TENX
TENX Stockholder Notice: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against Tenax Therapeutics, Inc.
prnewswire.com
TENX
Pomerantz Law Firm Announces the Filing of a Class Action Against Tenax Therapeutics, Inc. and Certain Officers - TENX
prnewswire.com
TENX
TENX Investors Have Opportunity to Lead Tenax Therapeutics, Inc. Securities Fraud Lawsuit
prnewswire.com
TENX
ATTENTION NASDAQ: TENX INVESTORS: Contact Berger Montague About a Tenax Therapeutics, Inc. Class Action Lawsuit
prnewswire.com
TENX
TENX INVESTOR ALERT: Tenax Therapeutics, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before December 28, 2026 Deadline
prnewswire.com
TENX